[Locally advanced and recurrent pelvic colorectal carcinoma: results of aggressive surgical treatment].
Pelvic exenteration has been described as a formidable procedure in cases of advanced or recurrent pelvic cancers for a variety of primary tumors, including colorectal, gynaecologic and urologic. We report our 14-year experience in a community hospital with 37 cases who underwent pelvic exenteration for recurrent (n = 15) or locally advanced (n = 22) colorectal cancers. At a median follow-up of 36 months, the median survival was 24 and 36 months, respectively, and the 5-year actuarial survival was 18% and 44%.
Vitelli
C E
CE
Ospedale MG Vannini, UOC di Chirurgia Generale e Oncologica, Roma.
Fortunato
L
L
Crenca
F
F
Di Nardo
A
A
Zarrelli
G
G
Farina
M
M
Bianca
S
S
D000328:Adult; D000368:Aged; D015179:Colorectal Neoplasms / Q000473:pathology* / Q000601:surgery*; D013505:Digestive System Surgical Procedures / Q000379:methods; D018450:Disease Progression; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000601:surgery*